Pharmacokinetic Properties of Acetyl Tributyl Citrate, a Pharmaceutical Excipient
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyeon | - |
dc.contributor.author | Choi, Min Sun | - |
dc.contributor.author | Ji, Young Seok | - |
dc.contributor.author | Kim, In Sook | - |
dc.contributor.author | Kim, Gi Beom | - |
dc.contributor.author | Bae, In Yong | - |
dc.contributor.author | Gye, Myung Chan | - |
dc.contributor.author | Yoo, Hye Hyun | - |
dc.date.accessioned | 2021-06-22T11:21:17Z | - |
dc.date.available | 2021-06-22T11:21:17Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/5084 | - |
dc.description.abstract | Acetyl tributyl citrate (ATBC) is an (the Food and Drug Administration) FDA-approved substance for use as a pharmaceutical excipient. It is used in pharmaceutical coating of solid oral dosage forms such as coated tablets or capsules. However, the information of ATBC on its pharmacokinetics is limited. The aim of this study is to investigate the pharmacokinetic properties of ATBC using liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. ATBC was rapidly absorbed and eliminated and the bioavailability was 27.4% in rats. The results of metabolic stability tests revealed that metabolic clearance may have accounted for a considerable portion of the total clearance of ATBC. These pharmacokinetic data would be useful in studies investigating the safety and toxicity of ATBC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Pharmacokinetic Properties of Acetyl Tributyl Citrate, a Pharmaceutical Excipient | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Hyun | - |
dc.identifier.doi | 10.3390/pharmaceutics10040177 | - |
dc.identifier.scopusid | 2-s2.0-85056111114 | - |
dc.identifier.wosid | 000455853800015 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, v.10, no.4, pp.1 - 10 | - |
dc.relation.isPartOf | Pharmaceutics | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.volume | 10 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PVC MEDICAL DEVICES | - |
dc.subject.keywordPlus | RAT PLASMA | - |
dc.subject.keywordPlus | PLASTICIZERS | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordAuthor | acetyl tributyl citrate | - |
dc.subject.keywordAuthor | pharmaceutical excipient | - |
dc.subject.keywordAuthor | pharmacokinetics | - |
dc.subject.keywordAuthor | metabolic stability | - |
dc.subject.keywordAuthor | plasma | - |
dc.identifier.url | https://www.mdpi.com/1999-4923/10/4/177 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.